These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 20033219
1. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Kaito H, Kamei K, Kikuchi E, Ogura M, Matsuoka K, Nagata M, Iijima K, Ito S. Pediatr Nephrol; 2010 May; 25(5):957-9. PubMed ID: 20033219 [Abstract] [Full Text] [Related]
2. Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis. Wee Leng G, Mustafar R, Kamaruzaman L, Mohd R, Cader RA, Wei Yen K, Kiew Bing P. Acta Med Indones; 2018 Jul; 50(3):237-243. PubMed ID: 30333274 [Abstract] [Full Text] [Related]
3. Rituximab for refractory focal segmental glomerulosclerosis. Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K. Pediatr Nephrol; 2008 Mar; 23(3):481-5. PubMed ID: 17973121 [Abstract] [Full Text] [Related]
4. Rituximab and low-dose cyclosporine combination therapy for steroid-resistant focal segmental glomerulosclerosis. Suyama K, Kawasaki Y, Miyazaki K, Kanno S, Ono A, Suzuki Y, Ohara S, Hosoya M. Pediatr Int; 2016 Mar; 58(3):219-223. PubMed ID: 26275234 [Abstract] [Full Text] [Related]
6. Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Fernandez-Fresnedo G, Segarra A, González E, Alexandru S, Delgado R, Ramos N, Egido J, Praga M, Trabajo de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN). Clin J Am Soc Nephrol; 2009 Aug; 4(8):1317-23. PubMed ID: 19578004 [Abstract] [Full Text] [Related]
7. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Suri M, Tran K, Sharma AP, Filler G, Grimmer J. Int Urol Nephrol; 2008 Aug; 40(3):807-10. PubMed ID: 18491215 [Abstract] [Full Text] [Related]
8. Low-dose methylprednisolone pulse therapy in Chinese children with steroid resistant focal segmental glomerulosclerosis. Chang JW, Yang LY, Wang HH. Pediatr Int; 2007 Jun; 49(3):349-54. PubMed ID: 17532834 [Abstract] [Full Text] [Related]
9. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report. Kolonko A, Piecha G, Więcek A. Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154 [Abstract] [Full Text] [Related]
10. Pulse methylprednisolone, cyclosporine, and ace inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis. Yorgin PD, Belson A, Higgins J, Alexander SR. Am J Kidney Dis; 2001 Jun; 37(6):E44. PubMed ID: 11382715 [Abstract] [Full Text] [Related]
11. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL. Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798 [Abstract] [Full Text] [Related]
12. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Gellermann J, Ehrich JH, Querfeld U. Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740 [Abstract] [Full Text] [Related]
13. A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification. Unagami K, Kawanishi K, Shimizu T, Kanzawa T, Toki D, Okumi M, Omoto K, Horita S, Koike J, Honda K, Nagashima Y, Ishida H, Tanabe K, Nitta K. Nephrology (Carlton); 2015 Jul; 20 Suppl 2():96-100. PubMed ID: 26031598 [Abstract] [Full Text] [Related]
14. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children. Kamei K, Ishikura K, Sako M, Ito S, Nozu K, Iijima K. Pediatr Nephrol; 2020 Jan; 35(1):17-24. PubMed ID: 30564879 [Abstract] [Full Text] [Related]
15. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis. Soyaltın E, Demir BK, Alparslan C, Çamlar SA, Alaygut D, Yavaşcan Ö, Mutlubaş F. Turk J Pediatr; 2020 Jan; 62(4):663-667. PubMed ID: 32779421 [Abstract] [Full Text] [Related]
16. Rituximab in treatment of collapsing FSGS-A case series. Girimaji N, Bharati J, Nada R, Rathi M, Kohli HS, Ramachandran R. Nephrology (Carlton); 2021 Feb; 26(2):134-141. PubMed ID: 32662534 [Abstract] [Full Text] [Related]
17. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Hari P, Bagga A, Jindal N, Srivastava RN. Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598 [Abstract] [Full Text] [Related]
18. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study. Soliman AR, Maamoun H, Soliman H, Ahmed RM. Rom J Intern Med; 2021 Jun 01; 59(2):127-133. PubMed ID: 33565308 [Abstract] [Full Text] [Related]
19. Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Kamei K, Okada M, Sato M, Fujimaru T, Ogura M, Nakayama M, Kaito H, Iijima K, Ito S. Pediatr Nephrol; 2014 Jul 01; 29(7):1181-7. PubMed ID: 24500706 [Abstract] [Full Text] [Related]
20. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Kamar N, Faguer S, Esposito L, Guitard J, Nogier MB, Durand D, Rostaing L. Clin Nephrol; 2007 Apr 01; 67(4):250-4. PubMed ID: 17474562 [Abstract] [Full Text] [Related] Page: [Next] [New Search]